Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05293912
Title SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.

chronic lymphocytic leukemia

multiple myeloma

Hodgkin's lymphoma

non-Hodgkin lymphoma

Waldenstroem's macroglobulinemia



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.